For professionals engaged in pharmaceutical research and development, the quality and purity of chemical intermediates are paramount. One such critical compound is (S)-3-Amino-4-(4-methylphenyl)butyric Acid Hydrochloride (CAS 270062-95-8). As a sophisticated chiral building block, this molecule plays a significant role in the synthesis of complex organic compounds, particularly within the realm of novel drug discovery and formulation. Understanding its properties and ensuring a reliable supply chain are key to successful research outcomes.

The demand for enantiomerically pure compounds has grown exponentially as researchers strive to develop more targeted and effective therapeutics. (S)-3-Amino-4-(4-methylphenyl)butyric Acid HCl, with its defined stereochemistry and high purity, is an invaluable tool in this endeavor. Its structure lends itself to incorporation into peptide mimetics, enzyme inhibitors, and various other biologically active molecules. The presence of the 4-methylphenyl group and the amino acid backbone offers unique opportunities for molecular design, influencing binding affinities and pharmacokinetic profiles.

When looking to buy this essential intermediate, it is crucial to partner with a reputable manufacturer and supplier. Especially when sourcing from China, the assurance of consistent quality and competitive price is vital. A reliable supplier will provide detailed specifications, including purity levels (typically 97% or higher) and the physical form (often an off-white to white solid or powder). This transparency builds confidence and ensures that the material procured meets the exact requirements for sensitive synthesis processes.

The applications of (S)-3-Amino-4-(4-methylphenyl)butyric Acid HCl extend beyond simple chemical synthesis. Researchers are exploring its potential in areas such as neurological disorders, metabolic diseases, and as a component in advanced peptide-based drug delivery systems. Its utility as a chiral intermediate means it can be employed in asymmetric synthesis to create stereospecific drug candidates, thereby enhancing efficacy and reducing potential side effects. For procurement managers and R&D scientists, identifying a consistent source for such specialized chemicals is a strategic priority.

In conclusion, for any pharmaceutical R&D project requiring high-purity chiral building blocks, (S)-3-Amino-4-(4-methylphenyl)butyric Acid HCl stands out as a compound of significant interest. By collaborating with established manufacturers and suppliers, particularly those based in China offering competitive pricing, you can ensure the integrity and success of your synthesis projects. Don't hesitate to reach out to trusted chemical providers to inquire about availability and secure your supply.